• Novobiocin in Reliable Cell Assays

  2026-09-14

  Learn how Novobiocin (SKU BA1116) can be incorporated into reproducible cell viability, proliferation, cytotoxicity, antiparasitic, and antiviral workflows. This scenario-based guide covers solvent controls, concentration selection, interpretation, and practical product-selection criteria.

• Vancomycin hydrochloride: Applied Research Workflows

  2026-09-13

  Vancomycin hydrochloride is more than a Gram-positive control: it can anchor antibiotic resistance assays, bacterial susceptibility testing, and selective recovery workflows. The reference study shows how vancomycin-based selection can improve Moraxella isolation from contaminated bovine specimens when paired with confirmation testing.

• 3-Deazaadenosine: An Assay-Design Guide

  2026-09-12

  3-Deazaadenosine is an S-adenosylhomocysteine hydrolase inhibitor for dissecting methylation-dependent biology. This guide connects its biochemical action with the METTL14–DHRS4-AS1 axis in ulcerative colitis and develops a practical framework for interpreting chemical perturbation in antiviral and inflammatory assays.

• ONX-0914 (PR-957) Immunoproteasome Research

  2026-09-11

  ONX-0914, also known as PR-957, is a selective LMP7 immunoproteasome inhibitor used to study cytokine regulation and immune-mediated disease models. Supplier-reported and peer-reviewed evidence supports applications in autoimmune, arthritis, diabetes, colitis, and airway inflammation research, while also showing that biological effects depend on tissue context.

• Necrostatin-1: RIP1 Kinase Inhibitor Workflows

  2026-09-11

  Necrostatin-1 provides a practical way to test whether inflammatory or tissue-injury phenotypes depend on RIP1-driven necroptosis. This guide connects cell-based necroptosis assays, AKI models, and ferroptosis-focused cancer research while emphasizing controls, formulation, and interpretation limits.

• D-Luciferin for Glioma Bioluminescence Imaging

  2026-09-10

  D-Luciferin potassium salt converts luciferase-labeled tumor burden into a longitudinal, non-invasive readout for glioma, cell-tracking, and reporter studies. This workflow-focused guide explains substrate preparation, IVIS timing, assay controls, and troubleshooting for more reproducible in vivo bioluminescence imaging.

• QNZ (EVP4593) for NF-κB Assay Design

  2026-09-10

  QNZ (EVP4593) provides a nanomolar pharmacological perturbation tool for connecting NF-κB activity with inflammatory cytokines, viability, and calcium signaling. Its value extends from Jurkat reporter assays to Huntington’s disease research, while the reference study suggests a practical framework for testing tissue-specific natural-product mechanisms.

• Etoposide (VP-16): From DNA Breaks to Translation

  2026-09-09

  Etoposide (VP-16) is more than a conventional DNA-damaging reagent: it is a translational benchmark for connecting topoisomerase II engagement, DNA double-strand break signaling, apoptosis, and cell-state selectivity. This article presents a practical framework for using Etoposide in DNA damage assays, cancer chemotherapy research, and exploratory senescence biology while distinguishing validated evidence from forward-looking hypotheses.

• EAGLE-1: Oral Gepotidacin for Gonorrhoea

  2026-09-09

  The phase 3 EAGLE-1 trial found that two oral doses of gepotidacin were non-inferior to ceftriaxone plus azithromycin for microbiological clearance of uncomplicated urogenital gonorrhoea. Its main innovation is clinical validation of a first-in-class oral antibacterial that inhibits bacterial DNA replication, providing a potential alternative treatment strategy as resistance reduces the usefulness of established therapies.

• A40926 Workflows for Cell Wall Antibiotic Research

  2026-09-08

  A40926 combines a defined cell-wall target with useful activity against MRSA, other Gram-positive pathogens, and Neisseria gonorrhoeae. This practical guide connects concentration-response testing, glycopeptide derivative work, and fermentation optimization to reproducible bench decisions.

• Bestatin (Ubenimex): Mechanism and Assay Use

  2026-09-08

  Bestatin, also called Ubenimex, is a research inhibitor of aminopeptidase B, leucine aminopeptidase, aminopeptidase N, and related zinc aminopeptidases. Its selective biochemical profile supports aminopeptidase activity measurement and multidrug resistance research, but assay conditions and cellular effects must be interpreted independently.

• Trypsin BA5744: From Proteolysis to Fusion Assays

  2026-09-07

  Trypsin is more than a routine protein digestion enzyme: its sequence-selective cleavage can become a deliberate variable in cell, inflammation, and membrane-fusion experiments. This article connects BA5744 handling with modern assay design and the membrane-localized nanotherapy concepts reported by Yu et al.

• QPRT Drives Breast Cancer Invasion via MLC Phosphorylation

  2026-09-07

  Liu et al. identify quinolinate phosphoribosyltransferase (QPRT) as a pro-invasive factor in breast cancer and connect its activity to purinergic signaling, Rho/ROCK, PLC, MLCK, and myosin light chain phosphorylation. The study combines tumor expression analysis, genetic perturbation, motility assays, and pharmacologic pathway dissection to position QPRT–MLCK signaling as a mechanistic framework for studying breast cancer invasion.

• Phosphotungstic Acid Negative Stain Solution: EM Guide

  2026-09-05

  Phosphotungstic Acid Negative Stain Solution (2%) provides a practical electron microscopy readout for particle morphology and sample quality. This guide connects coronavirus glycan biology with rigorous image interpretation while clarifying what negative stain electron microscopy can—and cannot—prove.

• A 83-01: From TGF-β Mechanism to Translation

  2026-09-04

  A mechanistic and strategic guide to using A 83-01 as an ALK-5 inhibitor in fibrosis, EMT, organoid, and translational research. The article connects TGF-β/Smad biology with LMCD1-driven corneal myofibroblast differentiation and outlines assay, selectivity, and decision-making considerations beyond a typical product page.

8077 records 1/539 page Next 12345 下5页 Last page